AL
AERI

Appaloosa LP’s Aerie Pharmaceuticals AERI Stock Holding History

Appaloosa LP’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-169,799
Closed -$8.25M – 61
2017
Q3 		$8.25M Sell
169,799
-20,000
-11% -$1.09M 0.12% 42
2017
Q2 		$9.97M Buy
+189,799
New +$8.84M 0.15% 53

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Appaloosa LP's AERI Position: Q4 2017 in Review

Appaloosa LP sold out of Aerie Pharmaceuticals (AERI) in Q4 2017, closing a stake of 169,799 shares — an estimated $8.25M sold.

Appaloosa LP first reported a position in AERI in Q2 2017 and held it in 2 quarters. The position peaked at $9.97M in Q2 2017. 179 funds tracked by Wall St. Rank hold AERI as of Q4 2017.

  • Appaloosa LP reported no remaining Aerie Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Appaloosa LP sold 169,799 Aerie Pharmaceuticals shares in Q4 2017, an estimated $8.25M.
  • Appaloosa LP first reported a position in Aerie Pharmaceuticals in Q2 2017 and held it in 2 quarters.
  • Appaloosa LP's Aerie Pharmaceuticals position peaked at $9.97M in Q2 2017.
  • 179 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2017.

Based on Appaloosa LP's 13F filing for Q4 2017, filed 14 Feb 2018.